Frontiers of commercial biotechnology: US and Japanese potential in a new industry |
| |
| Affiliation: | 1. Lusófona University, HEI-Lab: Digital Human-Environment Interaction Labs, Porto, Portugal;2. ISPA – University Institute, William James Center for Research, Lisboa, Portugal;3. University of Minho, Psychology Research Center (CIPsi), Braga, Portugal;1. Universidade Federal da Bahia, Faculdade de Medicina, Departamento de Pediatria, Salvador, BA, Brazil;2. Ambulatório de Transtornos Alimentares do C- HUPES (ATAH), Departamento de Pediatria, Salvador, BA, Brazil |
| |
| Abstract: | With their godlike ability to alter life and cure disease, the new biotechnologies have moved swiftly out of the laboratory and into various scientific and commercial applications. The small, innovative biotechnology firm has been the principal vehicle for the transition and it has been resoundingly supported by US venture capital and equity markets. Wall Street's support, however, could quickly evaporate, especially if major advances against cancer and AIDS are not soon forthcoming. With increasing Japanese interest in this field, there could be major industrial changes at the frontiers of commercial biotechnology. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
